EDGAR Filing Documents for 0001193125-24-122506

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

SEC Accession No. 0001193125-24-122506

Filing Date

2024-04-29

Accepted

2024-04-29 16:33:41

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-1/A	d827405ds1a.htm	S-1/A	433103
2	EX-23.1	d827405dex231.htm	EX-23.1	2004
3	GRAPHIC	g827405g85a01.jpg	GRAPHIC	47299
	Complete submission text file	0001193125-24-122506.txt		501416

Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339

Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419

Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 263407249 | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-278844 | Film No.: 24891595
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)